STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
RaySearch Laboratories AB (STO:RAYB) announces that version 2.5 of RaySearch’s RayStation® treatment planning system has been released for clinical use in Europe and USA and is pending regulatory approval in Canada. The new version includes a wide range of new features and improvements.
